Acasti Pharma, Inc. (ACST)
How ACST actually reacts to news — the realized, point-in-time move the market made, measured across 94 labeled events over the last three years with zero look-ahead.
ACST’s median reaction, across the day.
Half of all Acasti Pharma, Inc. news events land between -1.54% and +1.91% at 30 minutes.
Reaction stats as of 2026-08-13. Reaction = percent move vs. the price at the news timestamp.
Email me when ACST moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ACST’s baseline. Nothing else.
Get “How ACST reacts to news” as a PDF.
A free one-page summary: ACST’s median reaction to news and the full breakdown by event type — the numbers on this page, in one page.
Recent ACST events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form EFFECT Grace Therapeutics, Inc. | SEC filing · Form EFFECT | SEC EDGAR | — | — | |
| Form S-3 Grace Therapeutics, Inc. | SEC filing · Form S-3 | SEC EDGAR | — | — | |
| Form 8-K Grace Therapeutics, Inc. For: Mar 03 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form D Grace Therapeutics, Inc. | SEC filing · Form D | SEC EDGAR | — | — | |
| Form 10-Q/A Grace Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Form 10-Q Grace Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Form 8-K Grace Therapeutics, Inc. For: Feb 13 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K Grace Therapeutics, Inc. For: Feb 10 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 10-Q Grace Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Form 8-K Grace Therapeutics, Inc. For: Nov 13 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K Grace Therapeutics, Inc. For: Oct 24 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Acasti Announces Corporate Name Change to Grace Therapeutics, Inc. | Press release | GlobeNewswire | +0.00% | -0.30% | |
| Form 8-K Acasti Pharma Inc. For: Oct 25 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.30% | |
| Form EFFECT Acasti Pharma Inc. | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | -0.30% | |
| Form POS AM Acasti Pharma Inc. | SEC filing · Form POS | SEC EDGAR | — | -3.82% | |
| Form S-8 Acasti Pharma Inc. | SEC filing · Form S-8 | SEC EDGAR | — | -3.82% | |
| Form S-8 POS Acasti Pharma Inc. | SEC filing · Form S-8 | SEC EDGAR | — | -3.82% | |
| Form 8-K Acasti Pharma Inc. For: Oct 01 | SEC filing · Form 8-K | SEC EDGAR | — | -3.82% | |
| Form 8-K Acasti Pharma Inc. For: Sep 30 | SEC filing · Form 8-K | SEC EDGAR | — | -0.33% | |
| Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104 | Press release | GlobeNewswire | — | +18.61% | |
| Form 8-K Acasti Pharma Inc. For: Sep 25 | SEC filing · Form 8-K | SEC EDGAR | — | +18.61% | |
| Acasti to Present at the Life Sciences Investor Forum | Press release | GlobeNewswire | — | -8.38% | |
| Form DEFA14A Acasti Pharma Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | +1.66% | |
| Acasti to Participate in the H.C. Wainwright 26th Annual Global Investment Conference | Press release | GlobeNewswire | — | -2.00% | |
| Form 8-K Acasti Pharma Inc. For: Aug 12 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +3.32% | |
| Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update | Press release | GlobeNewswire | -0.18% | -3.28% | |
| Form 10-Q Acasti Pharma Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.18% | -3.28% | |
| Form 8-K Acasti Pharma Inc. For: Aug 09 | SEC filing · Form 8-K | SEC EDGAR | -0.18% | -3.28% | |
| Form DEFA14A Acasti Pharma Inc. | SEC filing · Form DEFA14A | SEC EDGAR | — | +0.00% | |
| Form EFFECT Acasti Pharma Inc. | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | -3.46% | |
| Form S-4/A Acasti Pharma Inc. | SEC filing · Form S-4 | SEC EDGAR | — | +0.37% | |
| Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial | Press release | GlobeNewswire | — | -1.68% | |
| Form 8-K Acasti Pharma Inc. For: Jun 27 | SEC filing · Form 8-K | SEC EDGAR | — | -1.68% | |
| Form S-4 Acasti Pharma Inc. | SEC filing · Form S-4 | SEC EDGAR | — | -1.68% | |
| Acasti Announces Year-End 2024 Financial Results, Provides Business Update | Press release | GlobeNewswire | +3.95% | +4.76% | |
| Form 10-K Acasti Pharma Inc. For: Mar 31 | SEC filing · Form 10-K | SEC EDGAR | +3.95% | +4.76% | |
| Form 8-K Acasti Pharma Inc. For: Jun 21 | SEC filing · Form 8-K | SEC EDGAR | +3.95% | +4.76% | |
| Acasti Pharma to Attend BIO International Convention 2024 | Press release | GlobeNewswire | — | +0.42% | |
| Form 8-K Acasti Pharma Inc. For: Apr 01 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.98% | |
| Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights | Press release | GlobeNewswire | +0.00% | +6.97% | |
| Form 10-Q Acasti Pharma Inc. For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +6.97% | |
| Form 8-K Acasti Pharma Inc. For: Feb 12 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +6.97% | |
| Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial | Press release | GlobeNewswire | +0.00% | -0.81% | |
| Form 8-K Acasti Pharma Inc. For: Jan 05 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.69% | |
| Form 8-K Acasti Pharma Inc. For: Dec 11 | SEC filing · Form 8-K | SEC EDGAR | +4.90% | +5.39% | |
| Acasti to Participate in Upcoming San Francisco Investor Conferences in January 2024 | Press release | GlobeNewswire | +0.00% | -0.47% | |
| Acasti Announces Second Quarter 2024 Financial Results and Business Highlights | Press release | GlobeNewswire | -1.40% | +0.47% | |
| Form 10-Q Acasti Pharma Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.40% | +0.47% | |
| Form 8-K Acasti Pharma Inc. For: Nov 13 | SEC filing · Form 8-K | SEC EDGAR | -1.40% | +0.47% | |
| Acasti Announces Dosing of First Patient in GTX-104 STRIVE-ON Trial | Press release | GlobeNewswire | +0.00% | -1.81% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ACST section they belong to.
More of the dataset.
ACST earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Acasti Pharma, Inc.'s median reaction calculated?
Every labeled ACST news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 94 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 47% of ACST's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-08-13.
Does ACST's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.